Please read our
Legal Terms page
The information on
this site is provided
on the basis that you
have understood and
accepted these terms

 

 

back to home page

 

 


Market Review

Quarter ending 31st December 2004

Equity markets performed well over the period, responding in part to a lead from the US following a conclusive result in the Presidential election and from a reversal of the sharp rise in commodity prices (led by Oil) over the prior quarter. In local currency terms all the major equity market indices rose over the period with the best returns once again from smaller company and technology stocks. However, the enormity of the US current account deficit continued to depress sentiment toward the US dollar leading to somewhat diminished returns from US$-denominated assets for non-US investors. Politics tended to dominate headlines with the Presidential election campaign in October, followed by the death of Yasser Arafat and the potential for a breakthrough in the Middle East, ending with the disputed Ukrainian election and increased tension between Moscow and the former Soviet Union state. However, all were metaphorically buried by the Asian tsunami: from this catastrophe has arisen a global humanitarian response that has transcended politics, race and religion.

In the UK, equity markets led returns over the quarter with the FTSE-100 index rising by 5.3% over the period. However, the best gains were experienced by the mid and small cap stocks, with rises of 10.7% and 8.0% respectively. Amongst sectors, the best returns were made within the Speciality Finance, Property and Tobacco stocks, the latter being driven by speculation of sector consolidation. After rallying over previous quarters, the Oil & Gas sector fell marginally during the period, as the price of Brent Crude retreated from the high in late October when it touched $52. The laggard within the UK market was the Pharmaceutical sector, closing down 3.5%. Sentiment toward large-cap pharmaceutical stocks was hit hard as companies on both sides of the Atlantic issued cautionary statements, a possible precursor to further regulatory moves by the FDA in the US. Over the course of the year the global pharmaceutical sector (which by coincidence was also lower by 3.5%) has lost more than $51bn in value.

US stocks performed well, rising by 7.0% and 8.7% as measured by the Dow Jones Industrial Average and S&P 500 indices respectively. Returns from technology stocks and smaller companies outweighed the large-cap stocks, with the Nasdaq composite and Russell 2000 indices rising 14.7% and 13.7%. The strength of the rally in smaller company stocks in the US was evident by the Russell 2000 index reaching a new all-time high toward the end of the period.

In Europe gains were made across the main indices with the EuroFirst 300 rising 8.3%. Among individual markets, Germany and France rose by 9.3% and 5.0%. During the quarter further downward revisions were made to the outlook for Euroland GDP in 2005, with just 2% expected on present forecasts, a small rise on 2004.
Asian markets also posted positive returns over the quarter despite continued debate over the durability of the Japanese recovery in the face of mixed economic data and concerns of slower activity from China in 2005. The Nikkei 225 index rose by 6.2% over the period and the more broadly based Topix index grew by 4.3%. Elsewhere in Asia rises of 7.3%, 4.1% and 8.5% were posted in South Korea, Singapore and Hong Kong. In Australia the ASX 200 closed at 4,050.6, a rise of 10.5% and just below the record high set in late December, reflecting a year of substantial gains from the mining heavyweights that constitute a large proportion of the index.

The rise in commodities was curtailed this quarter by the decline in Oil, which (as measured by Brent crude) fell by 14.5% to close the period at $40.24. The price fluctuated significantly over the quarter with a trading range of between $36.54 and $52. The broader CRB Commodities Index closed largely unchanged, down by 0.4%, whilst gold continued its rally largely driven by a weaker US dollar to close at $438.45, a rise of 4.8%.

Currency markets continued to de-rate the US dollar, and by the close Sterling had risen by 5.9% to $1.9181 and the Euro by 9.0% to $1.3554, a record high for the Eurozone currency against the greenback. The dollar also fell by 6.7% against the Japanese Yen to 102.6 by the close. The Euro rose against Sterling by 2.9% over the period, placing further downward pressure on Eurozone economic forecasts and helping to underpin bond valuations.
Bond markets in the UK rallied as further evidence of the weakness in the housing market provided support to the view that interest rates may be near their peak. The 10-year Gilt yield fell from 4.83% to close at 4.54%. In the US yields rose over the quarter to close at 4.22%, having fallen below 4% on concern over a slowdown for the economy in late October as the Oil price reached its peak during the quarter.

Datasource: Bloomberg

back to Market Review index



Copyright © 2007 Close Wealth Management Group - All rights reserved.
Close Private Asset Management Limited is authorised and regulated by the Financial Services Authority and offers services only available in the UK. Close Private Asset Management Limited is registered in England No 1644127, with its registered office at 10 Crown Place, London EC2A 4FT and is a subsidiary of Close Brothers Group plc. It is a member of APCIMS. Close Wealth Management Group is the trading name of a group of companies that includes Close Private Asset Management Limited.